ALIGARH, Feb. 5 -- Private Partnership (PPP) with Molecular Diagnostics and Therapy LLP to establish a state-of-the-art ...

Europe in vitro diagnostics (IVD) market is experiencing significant growth, driven by an aging population, rising chronic ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market.

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

IMDX is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.13 since the market last closed. This is a 1.90% ...

Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup (“ELITech”) for €870 million in cash, excluding the carved out ...